pan
viral
dna
microarray
detect
known
novel
multipl
viral
infect
major
laboratori
asset
contribut
control
infecti
diseas
larg
quantiti
ribosom
rna
rrna
found
tissu
sampl
thought
major
factor
contribut
compar
lower
sensit
detect
rna
virus
sequenceindepend
pcr
use
amplifi
unknown
sampl
microarray
analysi
studi
aim
determin
whether
deplet
exclus
rrna
improv
microarray
detect
simplifi
analysi
therefor
two
differ
rrna
deplet
exclus
protocol
ribominu
tm
technolog
nonrrna
bind
hexanucleotid
appli
microarray
sampl
process
outcom
compar
sequenceindepend
amplif
protocol
studi
conclud
two
procedur
describ
deplet
exclud
rrna
neglig
effect
microarray
detect
analysi
might
combin
techniqu
result
signific
enhanc
sensit
current
exist
protocol
random
amplif
background
adjust
pertin
purpos
sampl
process
microarray
analysi
crown
control
viral
diseas
reliant
identifi
caus
agent
order
help
devis
implement
appropri
control
measur
viru
identif
less
challeng
probe
known
viral
diseas
particular
characterist
clinic
sign
howev
viral
diseas
pathognomon
therefor
challeng
diagnos
case
unknown
new
virus
involv
detect
assay
depend
avail
antibodi
antigen
sequenc
inform
often
lack
investig
novel
diverg
pathogen
infecti
diseas
emerg
continu
new
speci
geograph
locat
due
factor
pathogen
mutat
genet
reassort
anim
human
movement
climat
chang
weiss
mcmichael
butler
regard
rna
virus
particular
concern
mutat
higher
rate
dna
virus
lack
proofread
enzym
prevent
error
rna
replic
holland
et
al
constant
threat
new
infecti
diseas
reiter
need
rapid
multiplex
detect
assay
microarray
probe
thousand
virus
simultan
addit
assay
potenti
detect
virus
close
relat
known
viral
pathogen
viral
coinfect
microarray
howev
come
without
challeng
ribosom
rna
rrna
estim
make
total
cellular
rna
compris
mostli
rrna
speci
mammal
de
vri
et
al
necessari
use
sequenc
independ
amplif
process
tissu
unknown
viral
diseas
result
coamplif
host
along
viral
nucleic
acid
nonspecif
amplif
also
thought
complic
interpret
readout
valu
due
cross
hybrid
rrna
may
also
compet
viral
rna
amplif
instig
lower
detect
sensit
ribosom
rna
deplet
method
ribominu
tm
technolog
life
technolog
paisley
uk
state
improv
microarray
analysi
gilbert
et
al
kang
et
al
ribominu
tm
protocol
rrna
molecul
deplet
total
rna
use
biotin
label
oligonucleotid
probe
hybrid
rrna
remov
streptavidinco
magnet
bead
procedur
found
reduc
larg
rrna
gilbert
et
al
endoh
colleagu
use
mix
nonrrna
bind
hexam
screen
hexam
exclud
rrna
molecul
amplif
procedur
claim
decreas
amount
nonspecif
amplif
enhanc
sensit
viru
discoveri
assay
hexam
also
shown
reduc
rrna
amplif
improv
sensit
next
gener
sequenc
ng
de
vri
et
al
hexam
also
increas
microarray
specif
simplifi
analyt
process
kang
et
al
studi
howev
look
virus
isol
cell
cultur
nasal
swab
analyt
process
microarray
also
complex
interpret
output
file
like
challeng
kang
et
al
although
bioinformat
tool
alreadi
develop
improv
simplifi
data
analysi
detectiv
softwar
watson
et
al
studi
also
look
optimis
sampl
process
reduc
genom
dna
optimis
hybrid
condit
han
et
al
kang
et
al
although
step
improv
microarray
detect
rate
significantli
cross
hybrid
compar
low
sensit
still
remain
problemat
test
tissu
sampl
studi
therefor
compar
applic
rrna
deplet
exclus
method
use
tissu
sampl
investig
either
method
improv
microarray
detect
rna
virus
simplifi
microarray
analysi
comparison
standard
random
prime
protocol
select
viru
posit
tissu
sampl
use
studi
tabl
tissu
sampl
homogenis
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
manchest
uk
tonsil
sampl
trizol
life
technolog
paisley
uk
brain
sampl
follow
manufactur
protocol
nucleic
acid
quantifi
use
nanodrop
spectromet
agil
technolog
cheshir
uk
dilut
concentr
g
l
nucleas
free
water
three
aliquot
l
subject
dnase
digest
use
amplif
grade
dnase
life
technolog
paisley
uk
briefli
l
dnase
buffer
l
dnase
enzym
unitsl
ad
l
nucleic
acid
extract
incub
c
min
l
mm
edta
ad
mix
incub
c
min
inactiv
dnase
enzym
ribosom
rna
remov
one
dnase
digest
aliquot
nucleic
acid
use
ribominu
tm
eukaryot
kit
rnaseq
life
technolog
paisley
uk
accord
manufactur
protocol
briefli
viral
extract
nucleic
acid
ad
l
ribominu
tm
probe
pmoll
l
hybrid
buffer
incub
c
min
sampl
transfer
prepar
ribominu
tm
magnet
bead
incub
c
min
bead
separ
use
magnet
leav
ribominu
tm
rna
target
rna
supernat
transfer
fresh
ribominu
tm
bead
sampl
incub
c
min
bead
separ
nucleic
acid
precipit
final
ethanol
resuspend
l
water
convert
cdna
use
random
prime
protocol
section
cdna
synthesi
use
random
primer
random
prime
tail
primer
gtt
tcc
cag
tca
cga
tan
nnn
nnn
nn
refer
hereaft
primer
use
gener
random
cdna
rrna
deplet
nucleic
acid
section
second
aliquot
nucleic
acid
describ
wang
et
al
briefli
l
mm
dntp
promega
southampton
uk
l
primer
ad
two
aliquot
mixtur
heat
c
min
chill
ice
immedi
l
rt
buffer
life
technolog
paisley
uk
l
dtt
l
rnasin
ribonucleas
inhibitor
ul
promega
l
superscript
iii
ul
life
technolog
paisley
uk
ad
mix
incub
c
min
c
min
c
min
stop
reaction
third
aliquot
nucleic
acid
convert
cdna
use
hexam
section
follow
random
prime
protocol
replac
primer
hexam
concentr
carri
describ
wang
et
al
minor
modif
cdna
gener
use
hexam
briefli
cdna
denatur
c
min
cool
c
ad
sequenas
enzym
mix
l
sequenas
buffer
affymetrix
high
wycomb
uk
l
sequenas
dna
polymeras
l
water
mix
cdna
gener
hexam
addit
l
primer
reaction
heat
c
min
period
use
veriti
thermocycl
life
technolog
paisley
uk
held
c
anoth
min
termin
c
min
amplif
doublestrand
dna
dsdna
perform
use
mix
contain
l
klentaq
pcr
buffer
sigmaaldrich
pool
dorset
uk
l
mm
dntp
mix
l
primer
aminob
gtt
tcc
cag
tca
cga
ta
l
klentaq
la
dna
polymeras
unitsl
l
templat
water
total
volum
l
thermal
profil
use
c
min
c
min
cycl
c
c
min
c
min
final
extens
c
min
amplifi
pcr
product
run
agaros
gel
sybr
safe
dna
gel
stain
life
technolog
paisley
uk
visualis
tran
uv
illumin
bio
rad
hertfordshir
uk
show
smear
bp
indirect
label
amplifi
dna
templat
l
perform
use
cycl
pcr
incorpor
amino
allyl
dutp
life
technolog
paisley
uk
reaction
gurrala
et
al
label
product
purifi
use
minelut
pcr
purif
kit
qiagen
manchest
uk
follow
manufactur
protocol
substitut
wash
buffer
ethanol
elut
sampl
l
water
fluoresc
dye
coupl
amino
allyl
label
pcr
product
ad
l
sodium
bicarbon
mg
ml
water
l
alexa
fluor
reactiv
dye
life
technolog
paisley
uk
reconstitut
l
dmso
elut
dna
vortex
incub
room
temperatur
dark
two
hour
coupl
reaction
made
volum
l
water
unincorpor
dye
remov
use
illustra
tm
autoseq
tm
dye
termin
remov
kit
ge
healthcar
buckinghamshir
uk
accord
manufactur
protocol
panvir
microarray
chip
use
studi
contain
probe
mer
around
viru
speci
chip
print
agil
technolog
cheshir
uk
k
format
sampl
could
process
simultan
hybrid
mix
compos
l
dna
mgml
kreatech
diagnost
east
sussex
uk
l
agil
block
agent
l
agil
hirpm
buffer
l
label
product
mix
heat
thermocycl
c
min
c
min
appli
onto
gasket
slide
microarray
slide
lower
onto
gasket
slide
secur
insid
agil
hybrid
chamber
chamber
place
preheat
rotat
hybrid
oven
agil
technolog
cheshir
uk
c
set
rotat
rpm
overnight
slide
whilst
attach
gasket
slide
submerg
room
temperatur
agil
oligo
acghchiponchip
wash
buffer
agil
technolog
cheshir
uk
remov
gasket
slide
microarray
slide
transfer
fresh
jar
buffer
wash
appli
magnet
stirrer
min
slide
transfer
subsequ
prewarm
c
buffer
wash
anoth
min
scan
slide
scan
microarray
agil
c
scanner
micron
resolut
instruct
manufactur
output
file
featur
extract
softwar
scanner
analys
use
detectiv
softwar
r
http
wwwrprojectorg
watson
et
al
use
data
unrel
experi
correct
background
nois
known
viru
sampl
use
compar
pvalu
andor
averag
valu
normalis
signal
intens
microarray
data
analysi
order
identifi
target
viru
viru
specif
real
time
pcr
mix
virus
except
rabi
viru
rv
compos
quantitect
viru
rox
vial
kit
qiagen
manchest
uk
forward
revers
primer
final
concentr
viru
specif
taqman
probe
final
concentr
rox
l
templat
dna
water
total
volum
l
mcgoldrick
et
al
lanciotti
et
al
marriott
et
al
bilk
et
al
thermal
profil
use
c
min
cycl
c
c
rrna
real
time
pcr
perform
use
l
rrna
primersprob
mix
life
technolog
paisley
uk
quantitect
viru
rox
vial
kit
describ
l
templat
dna
rv
l
brilliant
ii
sybr
green
qpcr
low
rox
master
mix
agil
technolog
cheshir
uk
use
primer
total
final
concentr
l
templat
dna
water
final
volum
l
wakeley
et
al
thermal
profil
use
c
min
cycl
c
min
c
c
sampl
test
duplic
notempl
control
ntc
also
includ
run
check
cross
contamin
background
nois
fifti
hexam
supplement
list
hexam
describ
endoh
et
al
select
verifi
present
equin
rrna
porcin
rrna
bovin
rrna
human
rrna
sequenc
access
number
respect
blast
program
sanger
institut
use
find
hit
hexam
sequenc
ensu
hexam
map
genom
sequenc
sever
virus
human
anim
import
tabl
assess
number
bind
site
hexam
viral
genom
also
measur
nucleotid
distanc
bind
site
among
virus
use
loup
ill
viru
liv
genom
lowest
bind
site
also
largest
distanc
bind
site
prompt
us
includ
viru
studi
evalu
effici
hexam
gener
cdna
furthermor
order
assess
whether
hexam
perform
could
influenc
low
viral
load
serial
dilut
classic
swine
fever
viru
csfv
posit
nucleic
acid
made
nucleic
acid
deriv
viru
neg
tissu
nucleic
acid
dilut
subject
cdna
synthesi
use
hexam
random
prime
follow
csfv
qpcr
quantifi
virusspecif
amplicon
ct
valu
obtain
qpcr
csfv
nucleic
acid
dilut
use
either
two
protocol
compar
minor
differ
averag
csfv
ct
valu
random
prime
compar
hexam
use
neat
csfv
dilut
respect
three
method
hexam
ribominu
tm
random
prime
produc
pcr
amplicon
expect
size
rang
smear
bp
agaros
gel
data
shown
use
csfv
liv
west
nile
viru
wnv
rv
posit
nucleic
acid
target
hexam
found
effici
random
prime
produc
cdna
even
virus
bind
site
hexam
liv
addit
use
hexam
result
evenli
spread
dna
smear
indic
arbitrari
amplif
total
nucleic
acid
viru
specif
qpcr
carri
quantifi
amount
viru
amplicon
obtain
viru
use
hexam
ribominu
tm
random
prime
protocol
tabl
consid
ct
valu
appear
pattern
suggest
three
protocol
contribut
higher
sensit
amplifi
viral
nucleic
acid
extract
tissu
sampl
remov
exclus
rrna
viru
posit
tissu
also
quantifi
rrna
qpcr
use
cdna
gener
hexam
ribominu
tm
random
prime
protocol
templat
tabl
cdna
gener
hexam
show
margin
effect
whilst
ribominu
tm
protocol
demonstr
clear
decreas
rrna
compar
cdna
gener
random
prime
protocol
effect
remov
rrna
microarray
specif
sensit
eas
data
interpret
assess
analys
microarray
output
three
protocol
seven
known
posit
viru
sampl
averag
pvalu
probe
fluoresc
intens
viru
calcul
detectiv
softwar
consid
interpret
microarray
output
hexam
ribominu
tm
random
prime
detect
rate
respect
p
valu
probe
signal
intens
consid
viru
identif
differ
detect
low
csfv
ribominu
tm
protocol
use
sampl
process
detect
rate
howev
three
protocol
averag
signal
intens
viru
probe
interrog
identifi
target
viru
investig
whether
deplet
exclus
rrna
could
reduc
cross
hybrid
target
viru
nucleic
acid
unrel
probe
microarray
proport
varianc
averag
probe
fluoresc
intens
top
viru
hit
unrel
virus
cascad
visualis
use
scree
plot
fig
supplement
visual
differ
reduct
cross
hybrid
frequenc
among
three
method
three
sampl
process
protocol
tabl
quantit
pcr
rrna
cdna
gener
use
hexam
ribominu
tm
random
prime
protocol
cycl
threshold
show
larg
differ
averag
frequenc
target
viru
unrel
viru
hit
enabl
clear
identif
target
viru
microarray
proven
success
tool
detect
novel
virus
viral
coinfect
establish
frontlin
diagnost
tool
investig
emerg
infecti
diseas
enhanc
assay
perform
therebi
simplifi
interpret
output
therefor
critic
use
routin
diagnost
test
improv
alreadi
made
analyt
process
use
statist
softwar
detectiv
watson
et
al
enabl
easier
analysi
interrog
microarray
output
mani
group
also
attempt
improv
sampl
prepar
han
et
al
kang
et
al
nicholson
et
al
whilst
other
work
deplet
rrna
extract
nucleic
acid
purpos
endoh
et
al
gilbert
et
al
kang
et
al
studi
look
implement
two
differ
rrna
deplet
exclus
method
assess
whether
improv
microarray
detect
rna
virus
tissu
sampl
could
made
ribominu
tm
technolog
nonrrna
bind
hexam
two
method
use
studi
compar
inus
random
prime
method
hexam
select
origin
describ
hexam
endoh
et
al
reduc
rrna
bind
hexam
order
increas
select
toward
viral
rna
hexam
hamper
amplif
viru
nucleic
acid
tissu
sampl
even
sampl
low
viral
load
howev
small
decreas
rrna
load
could
achiev
hexam
repercuss
microarray
detect
contrari
de
vri
et
al
found
nonrrna
bind
hexam
reduc
rrna
amplif
fold
depend
region
rrna
genom
use
quantif
work
howev
carri
use
nasopharyng
swab
trivial
amount
cell
contamin
comparison
tissu
sampl
furthermor
commerci
primersprob
mix
use
studi
possibl
verifi
region
rrna
genom
target
pcr
comparison
ribominu
tm
technolog
success
remov
rrna
larg
extent
also
indic
research
gilbert
et
al
howev
differ
microarray
detect
observ
compar
random
prime
protocol
especi
appli
deplet
rrna
sampl
low
viral
load
may
due
length
nucleic
acid
handl
time
sever
step
separ
wash
ribominu
tm
protocol
caus
degrad
poor
recoveri
viral
nucleic
acid
therefor
protocol
may
remov
rrna
effect
meantim
affect
advers
viral
nucleic
acid
integr
addit
ribominu
tm
technolog
compar
expens
time
consum
restrict
applic
high
throughput
test
sought
reason
would
unrealist
justifi
implement
ribominu
tm
technolog
unless
highli
effect
improv
test
confirm
microarray
howev
ribominu
tm
similar
technolog
may
prove
benefici
enrich
pathogen
specif
sequenc
ng
librari
prepar
complex
matric
eg
tissu
sampl
whole
microarray
result
three
method
show
differ
overal
detect
rate
amount
cross
hybrid
seen
kang
et
al
found
nonribosom
hexanucleotid
improv
microarray
specif
howev
sampl
use
evalu
viru
isol
often
contain
small
amount
cellular
contamin
therefor
repres
tissu
sampl
use
microarray
analysi
intend
clinic
applic
addit
host
genom
remov
prior
nucleic
acid
extract
experi
carri
nonrrna
oligonucleotid
may
account
improv
script
use
run
detectiv
softwar
may
also
major
contribut
factor
equal
perform
three
protocol
seen
studi
especi
analys
cross
hybrid
softwar
employ
script
instruct
subtract
floresc
data
unrel
sampl
intest
sampl
background
adjust
alreadi
minimis
effect
cross
hybrid
signal
may
contribut
compar
outcom
three
protocol
import
use
signal
averag
addit
pvalu
microarray
analysi
also
identifi
detect
rate
found
lower
use
pvalu
due
variabl
signal
intens
among
individu
probe
probe
number
repres
viru
origin
work
describ
detectiv
softwar
watson
et
al
reli
p
valu
analys
microarray
output
final
tissu
sampl
experiment
condit
harbour
higher
load
rrna
compar
cell
cultur
isol
may
render
lower
effici
rrna
exclus
hexam
short
length
hexam
consequ
nonspecif
bind
may
also
contribut
find
studi
therefor
longer
oligonucleotid
eg
nonam
may
applic
conclus
studi
identifi
two
rrna
deplet
exclus
protocol
signific
effect
microarray
detect
reduct
cross
hybrid
accordingli
current
random
amplif
background
adjust
protocol
pertin
purpos
investig
novel
emerg
diseas
via
microarray
analysi
whilst
find
also
emphas
import
select
appropri
sampl
analysi
protocol
suggest
improv
nucleic
acid
prepar
also
includ
tissu
sampl
valid
intend
diagnost
purpos
studi
conclud
two
procedur
ribominu
tm
technolog
nonrrna
bind
hexanucleotid
describ
deplet
exclud
rrna
littl
effect
microarray
detect
analysi
might
combin
techniqu
result
signific
enhanc
sensit
current
exist
protocol
random
amplif
background
adjust
pertin
purpos
sampl
process
microarray
analysi
